CIBC Asset Management
SMMT icon

CIBC Asset Management’s Summit Therapeutics SMMT Stock Holding History

CIBC Asset Management’s Portfolio SMMT Stock Details SMMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$354K Hold
24,289
– – ﹤0.01% 952
2026
Q1 		$461K Hold
24,289
– – ﹤0.01% 825
2025
Q4 		$425K Buy
24,289
+2,166
+10% +$40.7K ﹤0.01% 843
2025
Q3 		$457K Hold
22,123
– – ﹤0.01% 797
2025
Q2 		$471K Hold
22,123
– – ﹤0.01% 772
2025
Q1 		$427K Buy
22,123
+546
+3% +$11K ﹤0.01% 775
2024
Q4 		$385K Buy
21,577
+1,132
+6% +$21.9K ﹤0.01% 801
2024
Q3 		$448K Buy
20,445
+740
+4% +$10.3K ﹤0.01% 764
2024
Q2 		$154K Buy
+19,705
New +$106K ﹤0.01% 1068

Other funds holding SMMT

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

CIBC Asset Management's SMMT Position: Q2 2026 in Review

CIBC Asset Management held its Summit Therapeutics (SMMT) position steady in Q2 2026 at 24,289 shares worth $354K. The position accounts for ﹤0.01% of the portfolio, ranked #952.

CIBC Asset Management first reported a position in SMMT in Q2 2024 and has held it in 9 quarters since. The position peaked at $471K in Q2 2025. 242 funds tracked by Wall St. Rank hold SMMT as of Q2 2026.

  • CIBC Asset Management held 24,289 shares of Summit Therapeutics worth $354K as of Q2 2026.
  • CIBC Asset Management left its Summit Therapeutics share count unchanged in Q2 2026.
  • Summit Therapeutics made up ﹤0.01% of CIBC Asset Management's portfolio in Q2 2026, its #952 holding.
  • CIBC Asset Management first reported a position in Summit Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • CIBC Asset Management's Summit Therapeutics position peaked at $471K in Q2 2025.
  • 242 funds tracked by Wall St. Rank held Summit Therapeutics as of Q2 2026.

Based on CIBC Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.